Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Mar 15, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assertio Holdings, Inc.
| -10.25K |
$1.12 | -$11,462.67 | -5.16% | 188.25K |
Mar 14
| |||||||
Genelux Corp
| -9.00K |
$13.22 | -$118,969.02 | -72.23% | 3.46K |
Dec 13
| |||||||
Genelux Corp
| 3.46K |
—
|
—
| +38.44% | 12.46K |
Sep 11
| |||||||
Assertio Holdings, Inc.
| 31.19K |
—
|
—
| +18.64% | 198.5K |
May 10
| |||||||
Assertio Holdings, Inc.
| -43.14K |
$6.00 | -$258,767.40 | -20.50% | 167.31K |
May 5
| |||||||
Genelux Corp
| 9K |
—
|
—
|
∞
| 9K |
Feb 17
| |||||||
Genelux Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
Chemocentryx, Inc.
| -9.14K |
—
|
—
| -100.00% |
0
|
Oct 20
| |||||||
Chemocentryx, Inc.
| -10.00K |
$50.22 | -$502,200.00 | -52.25% | 9.14K |
Aug 4
|
Scheduled
| ||||||
Chemocentryx, Inc.
| -3.86K |
$25.66 | -$99,129.47 | -16.79% | 19.14K |
Jun 9
|
Scheduled
| ||||||
Chemocentryx, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 26
| |||||||
Chemocentryx, Inc.
| 7.73K |
—
|
—
| +50.58% | 23K |
May 20
| |||||||
Assertio Holdings, Inc.
| -44.64K |
$2.36 | -$105,169.98 | -17.50% | 210.45K |
May 12
|
Scheduled
| ||||||
Assertio Holdings, Inc.
| 86.29K |
—
|
—
| +51.11% | 255.09K |
May 4
| |||||||
Chemocentryx, Inc.
|
0
|
$24.12 | -$817,414.70 |
—
| 15.28K |
Dec 17
|
Scheduled
| ||||||
Chemocentryx, Inc.
| 2.21K |
$9.76 | -$23,955.95 | +16.88% | 15.28K |
May 20 - May 21
|
Scheduled
| ||||||
Assertio Holdings, Inc.
| 357.14K |
—
|
—
| +112.28% | 675.23K |
May 11
| |||||||
Chemocentryx, Inc.
| 7.72K |
—
|
—
| +144.51% | 13.07K |
May 21 - May 23
| |||||||
Assertio Holdings, Inc.
| 237.5K |
—
|
—
| +294.70% | 318.09K |
May 19
| |||||||
Chemocentryx, Inc.
| -30.00K |
$37.06 | -$1,111,686.32 | -84.88% | 5.34K |
Jan 13
|
Scheduled
| ||||||
Chemocentryx, Inc.
| 8.42K |
—
|
—
| +31.28% | 35.34K |
May 21 - May 23
| |||||||
Assertio Therapeutics, Inc
| 70.83K |
—
|
—
| +726.06% | 80.59K |
May 7 - May 8
| |||||||
Chemocentryx, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 21
| |||||||
Depomed Inc
|
0
|
—
|
—
|
—
|
0
|
May 8
| |||||||
Depomed Inc
|
0
|
—
|
—
|
—
|
0
|
Aug 15
| |||||||
Chemocentryx, Inc.
| 33.27K |
—
|
—
| +161.72% | 53.85K |
May 25 - May 26
| |||||||
Innoviva, Inc.
| 19.86K |
—
|
—
| +39.17% | 70.55K |
Apr 20
| |||||||
Depomed Inc
|
0
|
—
|
—
|
—
|
0
|
Oct 17
| |||||||
Depomed Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Chemocentryx, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 26
| |||||||
Chemocentryx, Inc.
| 6.25K |
$4.39 | -$24,337.05 | +43.64% | 20.57K |
May 21 - May 23
|
Scheduled
| ||||||
Innoviva, Inc.
| -813.00 |
$10.47 | -$8,512.11 | -1.58% | 50.7K |
May 18
|
Scheduled
| ||||||
Innoviva, Inc.
| 18.33K |
—
|
—
| +51.45% | 53.95K |
Apr 26
| |||||||
Theravance Inc
| -2.44K |
$16.85 | -$41,080.30 | -6.84% | 33.18K |
Jun 2
|
Scheduled
| ||||||
Chemocentryx, Inc.
| 14.32K |
$7.45 | -$94,592.89 |
∞
| 14.32K |
May 21 - May 22
|
Scheduled
| ||||||
Theravance Inc
| 13.95K |
—
|
—
| +64.37% | 35.62K |
Apr 24
| |||||||
Theravance Inc
| 6.5K |
—
|
—
| +42.85% | 21.67K |
Dec 22
| |||||||
Theravance Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Theravance Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Theravance Inc
| 15.17K |
—
|
—
|
∞
| 15.17K |
Jun 2
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.